Cargando…

Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial

BACKGROUND: Edaravone Dexborneol is a novel neuroprotective agent that comprised edaravone and (+)-borneol, a food additive with an anti-inflammatory effect in animal ischaemic stroke models. This study aims to assess the safety and efficacy of Edaravone Dexborneol compared with edaravone in treatin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jie, Wang, Yilong, Wang, Anxin, Gao, Zhiqiang, Gao, Xiaoping, Chen, Huisheng, Zhou, Junshan, Zhao, Xingquan, Wang, Yongjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812637/ https://www.ncbi.nlm.nih.gov/pubmed/31709115 http://dx.doi.org/10.1136/svn-2018-000221

Ejemplares similares

Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study
por: Shi, Fenghao, et al.
Publicado: (2022)

Edaravone Dexborneol Alleviates Cerebral Ischemic Injury via MKP-1-Mediated Inhibition of MAPKs and Activation of Nrf2
por: Zhang, Wen, et al.
Publicado: (2022)

Edaravone Dexborneol Downregulates Neutrophil Extracellular Trap Expression and Ameliorates Blood-Brain Barrier Permeability in Acute Ischemic Stroke
por: Huang, Yuanxiang, et al.
Publicado: (2022)

Edaravone dexborneol protects cerebral ischemia reperfusion injury through activating Nrf2/HO‐1 signaling pathway in mice
por: Xu, Lili, et al.
Publicado: (2022)

Docetaxel-induced cognitive impairment in rats can be ameliorated by edaravone dexborneol: Evidence from the indicators of biological behavior and anisotropic fraction
por: Liu, Ping, et al.
Publicado: (2023)

Edaravone Dexborneol Treatment Attenuates Neuronal Apoptosis and Improves Neurological Function by Suppressing 4-HNE-Associated Oxidative Stress After Subarachnoid Hemorrhage
por: Chen, Qian, et al.
Publicado: (2022)

Effects of edaravone dexborneol on neurological function and serum inflammatory factor levels in patients with acute anterior circulation large vessel occlusion stroke
por: Hu, Xiaohong, et al.
Publicado: (2023)

Effects of Butylphthalide Sodium Chloride Injection Combined with Edaravone Dexborneol on Neurological Function and Serum Inflammatory Factor Levels in Sufferers Having Acute Ischemic Stroke
por: Li, Keliang, et al.
Publicado: (2022)

Retracted: Effects of Butylphthalide Sodium Chloride Injection Combined with Edaravone Dexborneol on Neurological Function and Serum Inflammatory Factor Levels in Sufferers Having Acute Ischemic Stroke
por: Healthcare Engineering, Journal of
Publicado: (2023)

Edaravone: a baby in the bathwater?
por: Ludolph, Albert
Publicado: (2017)

Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study
por: Li, Shuya, et al.
Publicado: (2021)

Renal safety evaluation of aspirin plus edaravone in patients with ischaemic stroke: a retrospective cohort study
por: Yang, Hui-qin, et al.
Publicado: (2022)

Role of edaravone in managemant of septic peritonitis
por: Elbaradey, Ghada Fouad, et al.
Publicado: (2016)

Clinical effects and safety of edaravone in treatment of acute ischaemic stroke: A meta‐analysis of randomized controlled trials
por: Chen, Chongyue, et al.
Publicado: (2021)

Edaravone combined with Shuxuening versus edaravone alone in the treatment of acute cerebral infarction: A systematic review and meta-analysis
por: Li, Liang-Da, et al.
Publicado: (2023)

Edaravone and cyclosporine A as neuroprotective agents for acute ischemic stroke
por: Matsumoto, Shohei, et al.
Publicado: (2018)

4-Cl-edaravone and (E)-2-chloro-3-[(E)-phenyldiazenyl]-2-butenoic acid are the specific reaction products of edaravone with hypochlorite
por: Amekura, Sakiko, et al.
Publicado: (2020)

Stereotactic Administration of Edaravone Ameliorates Collagenase‐Induced Intracerebral Hemorrhage in Rat
por: Zhang, Yan, et al.
Publicado: (2016)

A radical scavenger edaravone and oligodendrocyte protection/regeneration
por: Takase, Hajime, et al.
Publicado: (2018)

Is Edaravone the Future of Free Radical Scavenging in Inflammatory States?
por: Nair, Abhijit S.
Publicado: (2017)

Effect of edaravone in diabetes mellitus-induced nephropathy in rats
por: Varatharajan, Rajavel, et al.
Publicado: (2016)

Synergy of Combined tPA-Edaravone Therapy in Experimental Thrombotic Stroke
por: Sun, Yu-Yo, et al.
Publicado: (2014)

Night-time diastolic blood pressure variability relates to stroke recurrence in patients who had ischaemic stroke with small artery occlusion
por: Wang, Tingting, et al.
Publicado: (2021)

Low serum albumin levels predict poor outcome in patients with acute ischaemic stroke or transient ischaemic attack
por: Zhou, Hongyu, et al.
Publicado: (2021)

Protective Effect of Edaravone on Glutamate-Induced Neurotoxicity in Spiral Ganglion Neurons
por: Bai, Xiaohui, et al.
Publicado: (2016)

Density Functional Theory (DFT) Study of Edaravone Derivatives as Antioxidants
por: Borges, Rosivaldo S., et al.
Publicado: (2012)

Inhibitory Effects of Edaravone in β-Amyloid-Induced Neurotoxicity in Rats
por: He, Feng, et al.
Publicado: (2014)

Stabilizers of edaravone aqueous solution and their action mechanisms. 2. Glutathione
por: Tanaka, Masahiko, et al.
Publicado: (2017)

Ethnical Disparities in Response to Edaravone in Patients With Amyotrophic Lateral Sclerosis
por: Jayasinghe, Maleesha, et al.
Publicado: (2022)

Antiviral Effect and Mechanism of Edaravone against Grouper Iridovirus Infection
por: Kuang, Jihui, et al.
Publicado: (2023)

How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?
por: Watanabe, Kazutoshi, et al.
Publicado: (2018)

Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke
por: Qian, Yun, et al.
Publicado: (2019)

Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2011)

Edaravone Inhibits the Production of Reactive Oxygen Species in Phagocytosis- and PKC-Stimulated Granulocytes from Multiple Sclerosis Patients Edaravone Modulate Oxidative Stress in Multiple Sclerosis
por: Villar-Delfino, Pedro Henrique, et al.
Publicado: (2022)

Efficacy of Butylphthalide in Combination with Edaravone in the Treatment of Acute Ischemic Stroke and the Effect on Serum Inflammatory Factors
por: Li, Yan, et al.
Publicado: (2023)

Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons
por: Ji Yuan, Wen, et al.
Publicado: (2008)

Solid Lipid Nanoparticles Loaded with Edaravone for Inner Ear Protection After Noise Exposure
por: Gao, Gang, et al.
Publicado: (2015)

Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients
por: Abe, Koji, et al.
Publicado: (2014)

Gastrointestinal bleeding during acute ischaemic stroke hospitalisation increases the risk of stroke recurrence
por: Du, Wanliang, et al.
Publicado: (2020)

Safety and efficacy of edaravone for patients with acute stroke: A protocol for randomized clinical trial
por: Shan, Hailei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1cm7rbhajrmfitm1vdqoua2mq4